RESULTS OF ADMINISTERING B.C.G. TO PATIENTS WITH MELANOMA
- 9 November 1974
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 304 (7889), 1096-1100
- https://doi.org/10.1016/s0140-6736(74)90867-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- FORMALIN-FIXED TUMOUR CELLS IN THE LEUCOCYTE MIGRATION TESTThe Lancet, 1973
- Management of Adult Acute Myelogenous LeukaemiaBMJ, 1973
- Antibody as carrier of chlorambucilCancer, 1972
- Immunological Effects of BCG in Malignant Melanoma: Two Modes of Administration ComparedAnnals of Internal Medicine, 1972
- Immunization with Irradiated Tumour Cells and Specific Lymphocyte Cytotoxicity in Malignant MelanomaBMJ, 1971
- Demonstration of cell‐mediated immunity to human neoplasms of various histological typesInternational Journal of Cancer, 1971
- Tumour-specific Antibodies in Human Malignant Melanoma and their Relationship to the Extent of the DiseaseBMJ, 1969
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969
- POSSIBLE IMMUNOLOGICAL FACTORS IN HUMAN MALIGNANT MELANOMA IN UGANDAThe Lancet, 1967
- SEPARATION OF VIABLE LYMPHOCYTES FROM HUMAN BLOODThe Lancet, 1964